Cancer-associated venous thrombosis is a common condition, although the reported
incidence varies widely between studies depending on patient population, start and duration …

Patients with cancer have an increased risk of both arterial and venous thrombotic events
compared with the general population. Both the site and stage of cancer are known to …

Background This guideline addressed VTE prevention in hospitalized medical patients,
outpatients with cancer, the chronically immobilized, long-distance travelers, and those with …

Background Ipsilateral breast tumor recurrence (IBTR) is the most common failure event
after lumpectomy for ductal carcinoma in situ (DCIS). We evaluated invasive IBTR (I-IBTR) …

This article discusses the prevention of venous thromboembolism (VTE) and is part of the
Antithrombotic and Thrombolytic Therapy: American College of Chest Physicians Evidence …

It is well known that there is a significant racial divide in breast cancer incidence and
mortality rates. African American women are less likely to be diagnosed with breast cancer …

Background The likelihood of distant recurrence in patients with breast cancer who have no
involved lymph nodes and estrogen-receptor–positive tumors is poorly defined by clinical …

Background: The finding of a decrease in contralateral breast cancer incidence following
tamoxifen administration for adjuvant therapy led to the concept that the drug might play a …

Thrombophilia is considered as a condition predisposing to the development of thrombosis.
Arterial thrombosis usually occurs after the erosion or rupture of an atherosclerotic plaque …

This article discusses the prevention of venous thromboembolism (VTE) and is part of the
Seventh American College of Chest Physicians Conference on Antithrombotic and …